Filter
5171
Filtered Results: 5171
Text search:
safety
of
workers
health
Featured
Recommendations
613
New Publications
1426
Language
Document type
No document type
2751
Guidelines
803
Studies & Reports
734
Manuals
330
Strategic & Response Plan
218
Fact sheets
121
Training Material
94
Situation Updates
61
Infographics
19
Brochures
15
Resource Platforms
14
Online Courses
8
Videos
2
App
1
Countries / Regions
India
189
Global
187
Kenya
154
Sierra Leone
148
Liberia
133
Nigeria
111
South Africa
108
Ethiopia
105
Uganda
99
Western and Central Europe
98
Syria
91
Nepal
86
Bangladesh
85
Myanmar / Burma
80
Malawi
63
Latin America and the Carribbean
63
Africa
63
Rwanda
60
Tanzania
59
Zambia
58
Ghana
56
Ukraine
53
Congo, Democratic Republic of
51
Philippines
50
Namibia
45
Guinea
44
South Sudan
44
West and Central Africa
33
South–East Asia Region
33
Yemen
30
East and Southern Africa
28
Middle East and North Africa
27
Lesotho
26
Asia
26
Zimbabwe
25
Russia
25
Cambodia
23
Indonesia
23
Mozambique
23
Brazil
23
Eastern Europe
23
Haiti
22
Afghanistan
21
Burkina Faso
20
Senegal
20
Botswana
19
Pakistan
18
Germany
18
Eastern Europe and Central Asia
18
Lebanon
17
USA
15
Vietnam
15
Jordan
14
Sudan
14
Central African Republic
13
Eswatini/ Swaziland
13
Western Pacific Region
13
Mali
12
Somalia
11
Cameroon
10
Iraq
10
Venezuela
10
Angola
9
Colombia
8
Palestine
8
Laos
8
Tajikistan
8
Moldova
8
Guinea-Bissau
7
Turkey
7
Thailand
7
China
7
Libya
7
Peru
6
Sri Lanka
6
Côte d’Ivoire / Ivory Coast
5
Papua New Guinea
5
Madagascar
5
Albania
5
Portugal
5
Niger
4
Benin
4
Argentina
4
Burundi
4
Bolivia
4
Chile
4
Poland
4
Romania
4
Iran
4
Georgia
4
North America
4
United Kingdom
4
Spain
4
Gambia
3
Croatia
3
Ecuador
3
Greece
3
Bhutan
3
Uzbekistan
3
Kazakhstan
3
Turkmenistan
3
Japan
3
Mauritius
3
Saudi Arabia
2
Togo
2
Egypt
2
Chad
2
North Macedonia
2
Hungary
2
El Salvador
2
Guatemala
2
Mexico
2
Fiji
2
Italy
2
Southern Africa
2
Timor Leste/ East Timor
2
Qatar
2
Estonia
2
Lithuania
2
Kyrgyzstan
2
Tunisia
2
Israel
2
Morocco
1
Malaysia
1
Ireland
1
Singapore
1
Switzerland
1
Serbia
1
Nicaragua
1
Paraguay
1
Djibouti
1
Armenia
1
Canada
1
Bulgaria
1
Gabon
1
Jamaica
1
France
1
Algeria
1
Azerbaijan
1
Belarus
1
French Guyana
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1841
Clinical Guidelines
379
Women & Child Health
326
Key Resources
318
Public Health
280
Capacity Building
118
Pharmacy & Technologies
54
Toolboxes
COVID-19
724
Mental Health
343
HIV
319
Ebola
247
Conflict
209
Caregiver
206
TB
191
Rapid Response
169
Disability
166
Planetary Health
155
AMR
140
Refugee
125
Pharmacy
114
Natural Hazards
87
Global Health Education
84
NTDs
63
NCDs
53
Specific Hazards
48
Cholera
31
Polio
27
Zika
22
Health Financing Toolbox
21
Social Ethics
16
South Sudan
2
Typhoon
1
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towar...
The WHO health advisory provides guidance to countries on adapting all existing preparedness and response plans and procedures for natural hazards such as cyclones, tropical storms, tornadoes, floods, earthquakes and potential outbreaks ... other diseases to their existing COVID-19 strategic preparedness and response plans. It advises countries to sustain all established public health and social measures to prevent and control COVID-19 while simultaneously preparing for responding to and effectively manage other disaster risks and events. It highlights WHO’s call for local, national, regional and global solidarity to support countries and communities with high levels of vulnerability to natural hazards during the COVID-19 pandemic.
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeter...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
The Regional strategy for measles control recommends that a second opportunity for measles immunization be provided to all children irrespective of their vaccination status or history of clinical me...
This guideline provides global, evidence-informed recommendations on daily iron supplementation in infants and children, as a public-health intervention for the prevention of anaemia and iron defici...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of...
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment ... malaria, third edition and the Guidelines for malaria vector control. Recommendations on malaria will continue to be reviewed and, where appropriate, updated based on the latest available evidence. Any updated recommendations will always display the date of the most recent revision in the MAGICapp platform. With each update, a new PDF version of the consolidated guidelines will also be available for download on the WHO website.
This version of the Guidelines includes updates to the case management of malaria, specifically the addition of new molecules for the treatment of uncomplicated malaria and optimization of the dosage regimen for anti-relapse treatment, along with updates on the use of antimalarial medicines in special risk populations including pregnant women.
Known avoidable environmental risks to health cause at least 12.6 million deaths every year, and account for about one quarter of the global burden of...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. ... plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy lives and promote well-being for all
at all ages”. It is also relevant to all the Sustainable Development Goals. Understanding the significance of the
role of health is a prerequisite for successful collective action on the social, economic and environmental
determinants of health
"Achieving, maintaining and improving accuracy, timeliness and reliability are major challenges for health laboratories. Countries worldwide committed themselves to build national capacities for the detection ..., and response to, public health events of international concern when they decided to engage in the International Health Regulations implementation process. Only sound management of quality in health laboratories will enable countries to produce test results that the international community will trust in cases of international emergency. This handbook is intended to provide a comprehensive reference on Laboratory Quality Management System for all stakeholders in health laboratory processes, from management, to administration, to bench-work laboratorians. This handbook covers topics that are essential for quality management of a public health or clinical laboratory. They are based on both ISO 15189 and CLSI GP26-A3 documents"--Page 7.
Pandemics and outbreaks have differential impacts on women and men. From risk of exposure and biological susceptibility to infection to the social and economic implications, individuals’ experiences are likely to vary according to ...
Several countries affected by COVID-19, have seen increases in levels of violence occurring in the home, including violence against children, intimate partner violence and violence against older people. Countries also face increasing challenges in m...
This technical guidance outlines current evidence, knowledge and best practice relating to incidences of violence and injuries among refugees and migrants in the WHO European Region. It highlights key principles, summarizes priority actions and chal...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use ... COVID-19 simulation exercises to test deployment strategies;
the indemnity agreement and no-fault compensation programme for vaccines secured through the COVAX Facility in the Advance Market Commitment (AMC) eligible economies;
the availability and use of the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool;
the COVAX Facility’s humanitarian buffer that enables allocation of vaccine to cover high-risk populations in humanitarian settings;
recommendations for vaccination of pregnant and lactating women;
supplementary information on infection prevention and control (IPC) measures to be used to deliver COVID-19 vaccines safely;
the WHO licensed COVID-19 vaccines product-specific information;
use of geospatial data and digital micro plans for equitable access and delivery of COVID-19 vaccines;
lessons learned from the development of NDVPs and early experiences in COVID-19 vaccine deployment in countries; and
updated additional resources at the end of each chapter.
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of...
Today more people are exposed to hazards. While humanitarian action to mitigate the impact of disasters will always be vitally important, the community is facing critical challenge- how to better anticipate, manage and reduce - disaster risks by int...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 Oc...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring ...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk ... CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
